Single Patient IND for the treatment of Leptomeningeal Metastases with Rhenium-186 NanoLiposome (186RNL)

ClinicalTrials.gov Identifier

ClinicalTrials.gov registration not required

Principal Investigator

Andrew Brenner, MD, PhD

For more information about this study

View Details